Takeda Pledges $30B in U.S., Argues Against Trump’s ‘Most Favored Nations’ Proposal

Takeda’s Julie Kim argues that Trump’s idea to match drug prices to that of other countries could cost the industry up to $1 trillion over the next 10 years.

Scroll to Top